Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2066911000168114 | Prostin E2 (dinoprostone 2 mg / 3 g) vaginal gel, 3 g syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2066921000168119 | Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | Is a | dinoprostone 2 mg/3 g vaginal gel, syringe | true | Inferred relationship | Some | ||
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | Is a | Prostin E2 | true | Inferred relationship | Some | ||
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | has manufactured dose form | vaginal gel | true | Inferred relationship | Some | ||
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | has unit of use | syringe | true | Inferred relationship | Some | 1034075671 | |
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | has Australian BoSS | dinoprostone | true | Inferred relationship | Some | 1034075670 | |
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | has intended active ingredient | dinoprostone | true | Inferred relationship | Some | 1034075670 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | has TPUU | True | Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | Inferred relationship | Some | 1 |
Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | has TPUU | True | Prostin E2 2 mg/3 g vaginal gel, 3 g syringe | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set